Literature DB >> 20352297

Warfarin: history, tautomerism and activity.

William R Porter1.   

Abstract

The anticoagulant drug warfarin, normally administered as the racemate, can exist in solution in potentially as many as 40 topologically distinct tautomeric forms. Only 11 of these forms for each enantiomer can be distinguished by selected computational software commonly used to estimate octanol-water partition coefficients and/or ionization constants. The history of studies on warfarin tautomerism is reviewed, along with the implications of tautomerism to its biological properties (activity, protein binding and metabolism) and chemical properties (log P, log D, pK (a)). Experimental approaches to assessing warfarin tautomerism and computational results for different tautomeric forms are presented.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20352297     DOI: 10.1007/s10822-010-9335-7

Source DB:  PubMed          Journal:  J Comput Aided Mol Des        ISSN: 0920-654X            Impact factor:   3.686


  46 in total

1.  A Brief Account of a Disease in Cattle Simulating Hemorrhagic Septicaemia due to Feeding Sweet Clover.

Authors:  F W Schofield
Journal:  Can Vet J       Date:  1984-12       Impact factor: 1.008

2.  Binding of drugs to human skin: influencing factors and the role of tissue lipids.

Authors:  K Walter; H Kurz
Journal:  J Pharm Pharmacol       Date:  1988-10       Impact factor: 3.765

3.  Interaction of warfarin with human serum albumin. A stoichiometric description.

Authors:  F G Larsen; C G Larsen; P Jakobsen; R Brodersen
Journal:  Mol Pharmacol       Date:  1985-02       Impact factor: 4.436

4.  Microscale determination of dissociation constants of multivalent pharmaceuticals by capillary electrophoresis.

Authors:  Y Ishihama; Y Oda; N Asakawa
Journal:  J Pharm Sci       Date:  1994-10       Impact factor: 3.534

5.  Structure of warfarin in solution.

Authors:  E J Valente; E C Lingafelter; W R Porter; W F Trager
Journal:  J Med Chem       Date:  1977-11       Impact factor: 7.446

6.  Enzymatic determinants of the substrate specificity of CYP2C9: role of B'-C loop residues in providing the pi-stacking anchor site for warfarin binding.

Authors:  R L Haining; J P Jones; K R Henne; M B Fisher; D R Koop; W F Trager; A E Rettie
Journal:  Biochemistry       Date:  1999-03-16       Impact factor: 3.162

Review 7.  Warfarin dose and the pharmacogenomics of CYP2C9 and VKORC1 - rationale and perspectives.

Authors:  Tong Yin; Toshiyuki Miyata
Journal:  Thromb Res       Date:  2006-12-11       Impact factor: 3.944

8.  Crystal structure analysis of warfarin binding to human serum albumin: anatomy of drug site I.

Authors:  I Petitpas; A A Bhattacharya; S Twine; M East; S Curry
Journal:  J Biol Chem       Date:  2001-04-02       Impact factor: 5.157

9.  Comparison of nine programs predicting pK(a) values of pharmaceutical substances.

Authors:  Chenzhong Liao; Marc C Nicklaus
Journal:  J Chem Inf Model       Date:  2009-12       Impact factor: 4.956

10.  Organocatalytic asymmetric Michael reaction of cyclic 1,3-dicarbonyl compounds and alpha,beta-unsaturated ketones--a highly atom-economic catalytic one-step formation of optically active warfarin anticoagulant.

Authors:  Nis Halland; Tore Hansen; Karl Anker Jørgensen
Journal:  Angew Chem Int Ed Engl       Date:  2003-10-20       Impact factor: 15.336

View more
  7 in total

1.  pK(a) based protonation states and microspecies for protein-ligand docking.

Authors:  Tim ten Brink; Thomas E Exner
Journal:  J Comput Aided Mol Des       Date:  2010-09-30       Impact factor: 3.686

2.  Tautomerism of Warfarin: Combined Chemoinformatics, Quantum Chemical, and NMR Investigation.

Authors:  Laura Guasch; Megan L Peach; Marc C Nicklaus
Journal:  J Org Chem       Date:  2015-09-25       Impact factor: 4.354

3.  Structural basis of antagonizing the vitamin K catalytic cycle for anticoagulation.

Authors:  Shixuan Liu; Shuang Li; Guomin Shen; Narayanasami Sukumar; Andrzej M Krezel; Weikai Li
Journal:  Science       Date:  2020-11-05       Impact factor: 47.728

4.  Pattern-free generation and quantum mechanical scoring of ring-chain tautomers.

Authors:  Daniel S Levine; Mark A Watson; Leif D Jacobson; Claire E Dickerson; Haoyu S Yu; Art D Bochevarov
Journal:  J Comput Aided Mol Des       Date:  2020-08-24       Impact factor: 3.686

5.  Enumeration of ring-chain tautomers based on SMIRKS rules.

Authors:  Laura Guasch; Markus Sitzmann; Marc C Nicklaus
Journal:  J Chem Inf Model       Date:  2014-09-09       Impact factor: 4.956

6.  Functionalized 4-hydroxy coumarins: novel synthesis, crystal structure and DFT calculations.

Authors:  Valentina Stefanou; Dimitris Matiadis; Georgia Melagraki; Antreas Afantitis; Giorgos Athanasellis; Olga Igglessi-Markopoulou; Vickie McKee; John Markopoulos
Journal:  Molecules       Date:  2011-01-07       Impact factor: 4.411

7.  Applications of the InChI in cheminformatics with the CDK and Bioclipse.

Authors:  Ola Spjuth; Arvid Berg; Samuel Adams; Egon L Willighagen
Journal:  J Cheminform       Date:  2013-03-13       Impact factor: 5.514

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.